April 28, 2023
BioPharma has experienced significant growth in recent years. This report by Robert Stoner and Jéssica Dutra, prepared for Pfizer, on the BioPharma Economic Impact in the US Economy demonstrates that the BioPharma industry in the United States provides significant value added to the GDP, a significant “multiplier” effect on employment and earnings, and a major R&D presence in the United States and worldwide.
In our latest white paper, Driving Transparency and Accountability: Saudi Arabia’s Expanding Reach in Enforcement and Disclosure, Managing Director Ralph Stobwasser and Director Tarek Bleik examine Saudi Arabia’s expanding enforcement activity and evolving transparency framework. The paper analyses the Kingdom’s approach to anti-corruption enforcement and financial transparency as part of its broader governance transformation under Vision 2030.
Reflecting on the Expert Strategy Led by Eric Poer in $450 Million Tax Credit Dispute
Eric Poer, a Managing Director in Secretariat’s Global Investigations & Disputes practice, led a forensic accounting team retained on behalf of Lehman Brothers’ unsecured creditors in connection with one of the largest bankruptcies in U.S. history.
First Things First: Why Technical Competence Must Precede AI Literacy for Lawyers
We are pleased to support the launch of a new white paper from Code & Counsel, sponsored by Secretariat and ACEDS.